Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Accumulated Depreciation & Amortization (2016 - 2025)

Prestige Consumer Healthcare has reported Accumulated Depreciation & Amortization over the past 16 years, most recently at $30.2 million for Q1 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $30.2 million for Q1 2025, down 1.64% from a year ago — trailing twelve months through Mar 2025 was $30.2 million (down 1.64% YoY), and the annual figure for FY2025 was $30.2 million, down 1.64%.
  • Accumulated Depreciation & Amortization for Q1 2025 was $30.2 million at Prestige Consumer Healthcare, down from $30.7 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for PBH hit a ceiling of $32.6 million in Q1 2023 and a floor of $30.2 million in Q1 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $30.7 million (2024), compared with a mean of $31.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: rose 6.39% in 2022 and later dropped 5.98% in 2024.
  • Prestige Consumer Healthcare's Accumulated Depreciation & Amortization stood at $30.2 million in 2021, then increased by 6.39% to $32.1 million in 2022, then grew by 1.66% to $32.6 million in 2023, then dropped by 5.98% to $30.7 million in 2024, then decreased by 1.64% to $30.2 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $30.2 million (Q1 2025), $30.7 million (Q1 2024), and $32.6 million (Q1 2023) per Business Quant data.